Deep Track Capital, LP 89bio, Inc. Put Options Transaction History
Deep Track Capital, LP
- $2.86 Billion
- Q1 2025
Put Options
1 transactions
Others Institutions Holding ETNB
# of Institutions
208Shares Held
160MCall Options Held
366KPut Options Held
944K-
Janus Henderson Group PLC London, X020.5MShares$189 Million0.09% of portfolio
-
Ra Capital Management, L.P. Boston, MA19.9MShares$184 Million3.0% of portfolio
-
Suvretta Capital Management, LLC New York, NY14.3MShares$132 Million4.56% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.16MShares$66.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.02MShares$64.8 Million0.0% of portfolio
About 89bio, Inc.
- Ticker ETNB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,484,500
- Market Cap $430M
- Description
- 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...